Skip to main content

United States News All stories

Every story in this section, newest first — page 201 of 373.

Grafa

Pulse Biosciences ramps R&D spending as commercialization of nsPFA technology begins

Pulse Biosciences (NASDAQ:PLSE) reported its financial results for the first quarter of 2026, marking a pivotal transition from a pure-research entity to early-stage commercialization of its proprietary nPulse™ technology.

Read more: Pulse Biosciences ramps R&D spending as commercialization of nsPFA technology begins